Despite growing evidence that cannabinoids such as CBD and THC can modulate cancer cell proliferation and survival, the molecular basis of these effects in ovarian cancer, particularly in relation to the PI3K/AKT/mTOR pathway and its upstream regulator PTEN, remain largely unexplained. This evidence concerns the gene PTEN and cancer.